{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,29]],"date-time":"2026-10-29T20:05:31Z","timestamp":1793304331718,"version":"4.5.0"},"reference-count":47,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2021,1,1]],"date-time":"2021-01-01T00:00:00Z","timestamp":1609459200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2021,1,1]],"date-time":"2021-01-01T00:00:00Z","timestamp":1609459200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2020,10,19]],"date-time":"2020-10-19T00:00:00Z","timestamp":1603065600000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["81803637"],"award-info":[{"award-number":["81803637"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","em-consulte.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Biomedicine &amp; Pharmacotherapy"],"published-print":{"date-parts":[[2021,1]]},"DOI":"10.1016\/j.biopha.2020.110912","type":"journal-article","created":{"date-parts":[[2020,11,18]],"date-time":"2020-11-18T13:10:41Z","timestamp":1605705041000},"page":"110912","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":30,"special_numbering":"C","title":["Metformin ameliorates olanzapine-induced insulin resistance via suppressing macrophage infiltration and inflammatory responses in rats"],"prefix":"10.1016","volume":"133","author":[{"given":"Cuilian","family":"Guo","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jinxin","family":"Liu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Huqun","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"3","key":"10.1016\/j.biopha.2020.110912_bib0005","doi-asserted-by":"crossref","first-page":"176","DOI":"10.4103\/0976-500X.114596","article-title":"Metabolic syndrome in schizophrenia: differences between antipsychotic-na\u00efve and treated patients","volume":"4","author":"Chadda","year":"2013","journal-title":"J. Pharmacol. Pharmacother."},{"issue":"2","key":"10.1016\/j.biopha.2020.110912_bib0010","doi-asserted-by":"crossref","first-page":"295","DOI":"10.1093\/schbul\/sbs082","article-title":"Is the prevalence of metabolic syndrome and metabolic abnormalities increased in early schizophrenia? A comparative meta-analysis of first episode, untreated and treated patients","volume":"39","author":"Mitchell","year":"2013","journal-title":"Schizophr. Bull."},{"issue":"7","key":"10.1016\/j.biopha.2020.110912_bib0015","doi-asserted-by":"crossref","first-page":"547","DOI":"10.2165\/00023210-200822070-00002","article-title":"Antipsychotic-induced weight gain in chronic and first-episode psychotic disorders: a systematic critical reappraisal","volume":"22","author":"Alvarez-Jim\u00e9nez","year":"2008","journal-title":"CNS Drugs"},{"key":"10.1016\/j.biopha.2020.110912_bib0020","article-title":"Olanzapine versus other atypical antipsychotics for schizophrenia","volume":"3","author":"Komossa","year":"2010","journal-title":"Cochrane Database Syst. Rev."},{"issue":"1","key":"10.1016\/j.biopha.2020.110912_bib0025","doi-asserted-by":"crossref","first-page":"155","DOI":"10.1007\/s00213-011-2555-2","article-title":"Gender-dependent consequences of chronic olanzapine in the rat: effects on body weight, inflammatory, metabolic and microbiota parameters","volume":"221","author":"Davey","year":"2012","journal-title":"Psychopharmacology (Berl)"},{"key":"10.1016\/j.biopha.2020.110912_bib0030","doi-asserted-by":"crossref","first-page":"167","DOI":"10.1016\/j.brainres.2010.05.060","article-title":"Olanzapine-induced accumulation of adipose tissue is associated with an inflammatory state","volume":"1350","author":"Montserrat","year":"2010","journal-title":"Brain Res."},{"issue":"12","key":"10.1016\/j.biopha.2020.110912_bib0035","doi-asserted-by":"crossref","first-page":"1161","DOI":"10.1177\/0269881114555250","article-title":"Effects of olanzapine on the elevation of macrophage infiltration and pro-inflammatory cytokine expression in female rats","volume":"28","author":"Zhang","year":"2014","journal-title":"J. Psychopharmacol."},{"issue":"6116","key":"10.1016\/j.biopha.2020.110912_bib0040","doi-asserted-by":"crossref","first-page":"218","DOI":"10.1126\/science.1227568","article-title":"JNK expression by macrophages promotes obesity-induced insulin resistance and inflammation","volume":"339","author":"Han","year":"2013","journal-title":"Science"},{"key":"10.1016\/j.biopha.2020.110912_bib0045","doi-asserted-by":"crossref","first-page":"1796","DOI":"10.1172\/JCI200319246","article-title":"Obesity is associated with macrophage accumulation in adipose tissue","volume":"112","author":"Weisberg","year":"2003","journal-title":"J. Clin. Invest."},{"issue":"5","key":"10.1016\/j.biopha.2020.110912_bib0050","doi-asserted-by":"crossref","first-page":"1171","DOI":"10.2337\/db09-1402","article-title":"Dynamic, M2-like remodeling phenotypes of cd11c+ adipose tissue macrophages during high-fat diet-induced obesity in mice","volume":"59","author":"Shaul","year":"2010","journal-title":"Diabetes"},{"key":"10.1016\/j.biopha.2020.110912_bib0055","doi-asserted-by":"crossref","first-page":"2446","DOI":"10.1002\/eji.201545502","article-title":"The\u201cBig Bang\u201d in obese fat: events initiating obesity-induced adipose tissue in\ufb02ammation","volume":"45","author":"Wensveen","year":"2015","journal-title":"Eur. J. Immunol."},{"key":"10.1016\/j.biopha.2020.110912_bib0060","doi-asserted-by":"crossref","first-page":"219","DOI":"10.1146\/annurev-physiol-021909-135846","article-title":"Macrophages, in\ufb02ammation, and insulin resistance","volume":"72","author":"Olefsky","year":"2010","journal-title":"Annu. Rev. Physiol."},{"key":"10.1016\/j.biopha.2020.110912_bib0065","doi-asserted-by":"crossref","first-page":"17","DOI":"10.1016\/j.molimm.2016.10.006","article-title":"Retinoid acid receptor-related orphan receptor alpha (ROR\u03b1) regulates macrophage M2 polarization via activation of AMPK\u03b1","volume":"80","author":"Xiao","year":"2016","journal-title":"Mol. Immunol."},{"issue":"4","key":"10.1016\/j.biopha.2020.110912_bib0070","doi-asserted-by":"crossref","first-page":"301","DOI":"10.1016\/j.cmet.2008.08.015","article-title":"Ablation of CD11c-positive cells normalizes insulin sensitivity in obese insulin resistant animals","volume":"8","author":"Patsouris","year":"2008","journal-title":"Cell Metab."},{"issue":"6","key":"10.1016\/j.biopha.2020.110912_bib0075","doi-asserted-by":"crossref","first-page":"496","DOI":"10.1016\/j.cmet.2008.04.003","article-title":"Alternative M2 activation of Kupffer cells by PPARdelta ameliorates obesity-induced insulin resistance","volume":"7","author":"Odegaard","year":"2008","journal-title":"Cell Metab."},{"issue":"5","key":"10.1016\/j.biopha.2020.110912_bib0080","doi-asserted-by":"crossref","first-page":"1566","DOI":"10.2337\/diabetes.54.5.1566","article-title":"Intensive lifestyle intervention or metformin on inflammation and coagulation in participants with impaired glucose tolerance","volume":"54","author":"Haffner","year":"2005","journal-title":"Diabetes"},{"issue":"4","key":"10.1016\/j.biopha.2020.110912_bib0085","doi-asserted-by":"crossref","first-page":"297","DOI":"10.1007\/s00592-011-0276-y","article-title":"The effects of rosiglitazone and metformin on inflammation and endothelial dysfunction in patients with type 2 diabetes mellitus","volume":"48","author":"Fidan","year":"2011","journal-title":"Acta Diabetol."},{"key":"10.1016\/j.biopha.2020.110912_bib0090","doi-asserted-by":"crossref","first-page":"60","DOI":"10.1016\/j.ejphar.2016.07.012","article-title":"Additional effect of metformin and celecoxib against lipid dysregulation and adipose tissue inflammation in high-fat fed rats with insulin resistance and fatty liver","volume":"789","author":"Lu","year":"2016","journal-title":"Eur. J. Pharmacol."},{"key":"10.1016\/j.biopha.2020.110912_bib0095","doi-asserted-by":"crossref","DOI":"10.1016\/j.biopha.2019.109131","article-title":"Effects of berberine and metformin on intestinal inflammation and gut microbiome composition in db\/db mice","volume":"118","author":"Zhang","year":"2019","journal-title":"Biomed. Pharmacother."},{"key":"10.1016\/j.biopha.2020.110912_bib0100","doi-asserted-by":"crossref","first-page":"256","DOI":"10.1016\/j.mce.2017.09.025","article-title":"Metformin improves obesity-associated inflammation by altering macrophages polarization","volume":"461","author":"Jing","year":"2018","journal-title":"Mol. Cell. Endocrinol."},{"key":"10.1016\/j.biopha.2020.110912_bib0105","doi-asserted-by":"crossref","first-page":"56","DOI":"10.1016\/j.lfs.2018.02.017","article-title":"Metformin ameliorates the progression of atherosclerosis via suppressing macrophage infiltration and inflammatory responses in rabbits","volume":"198","author":"Yang","year":"2018","journal-title":"Life Sci."},{"issue":"5","key":"10.1016\/j.biopha.2020.110912_bib0110","doi-asserted-by":"crossref","first-page":"537","DOI":"10.1111\/j.1365-2710.2011.01255.x","article-title":"A systematic review of metformin to limit weight-gain with atypical antipsychotics","volume":"36","author":"Lee","year":"2011","journal-title":"J. Clin. Pharm. Ther."},{"issue":"3","key":"10.1016\/j.biopha.2020.110912_bib0115","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0093310","article-title":"Metformin and berberine prevent olanzapine-induced weight gain in rats","volume":"9","author":"Hu","year":"2014","journal-title":"PLoS One"},{"issue":"2","key":"10.1016\/j.biopha.2020.110912_bib0120","doi-asserted-by":"crossref","first-page":"625","DOI":"10.1124\/jpet.102.046987","article-title":"Antipsychotic dosing in preclinical models is often unrepresentative of the clinical condition: a suggested solution based on in vivo occupancy","volume":"305","author":"Kapur","year":"2013","journal-title":"J. Pharmacol. Exp. Ther."},{"key":"10.1016\/j.biopha.2020.110912_bib0125","doi-asserted-by":"crossref","first-page":"379","DOI":"10.3389\/fphar.2018.00379","article-title":"The wnt signaling pathway effector TCF7L2 mediates olanzapine-induced weight gain and insulin resistance","volume":"9","author":"Li","year":"2018","journal-title":"Front. Pharmacol."},{"issue":"6","key":"10.1016\/j.biopha.2020.110912_bib0130","doi-asserted-by":"crossref","first-page":"407","DOI":"10.1503\/jpn.110140","article-title":"Differential effects of 3 classes of antidiabetic drugs on olanzapine-induced glucose dysregulation and insulin resistance in female rats","volume":"37","author":"Boyda","year":"2012","journal-title":"J. Psychiatry Neurosci."},{"issue":"3","key":"10.1016\/j.biopha.2020.110912_bib0135","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0093310","article-title":"Metformin and berberine prevent olanzapine-induced weight gain in rats","volume":"9","author":"Hu","year":"2014","journal-title":"PLoS One"},{"key":"10.1016\/j.biopha.2020.110912_bib0140","doi-asserted-by":"crossref","DOI":"10.1038\/srep44845","article-title":"Odd chain fatty acids; new insights of the relationship between the gut microbiota, dietary intake, biosynthesis and glucose intolerance","volume":"7","author":"Jenkins","year":"2017","journal-title":"Sci. Rep."},{"issue":"10","key":"10.1016\/j.biopha.2020.110912_bib0145","doi-asserted-by":"crossref","first-page":"2165","DOI":"10.1007\/s00125-014-3316-7","article-title":"Maternal vitamin D deficiency during pregnancy results in insulin resistance in rat offspring, which is associated with inflammation and I\u03bab\u03b1 methylation","volume":"57","author":"Zhang","year":"2014","journal-title":"Diabetologia"},{"key":"10.1016\/j.biopha.2020.110912_bib0150","doi-asserted-by":"crossref","first-page":"446","DOI":"10.3389\/fnmol.2018.00446","article-title":"Vascular gap junctions contribute to forepaw stimulation-induced vasodilation differentially in the pial and penetrating arteries in isoflurane-anesthetized rats","volume":"11","author":"Watanabe","year":"2018","journal-title":"Front. Mol. Neurosci."},{"key":"10.1016\/j.biopha.2020.110912_bib0155","doi-asserted-by":"crossref","first-page":"620","DOI":"10.3389\/fpsyt.2018.00620","article-title":"Effect of Betahistine and metformin on antipsychotic-induced weight gain: an analysis of two clinical trials","volume":"9","author":"Kang","year":"2018","journal-title":"Front. Psychiatry"},{"issue":"1","key":"10.1016\/j.biopha.2020.110912_bib0160","doi-asserted-by":"crossref","first-page":"67","DOI":"10.9758\/cpn.2020.18.1.67","article-title":"Metformin attenuates liver fat content: finding from schizophrenia patients with olanzapine-induced weight gain","volume":"18","author":"Wang","year":"2020","journal-title":"Clin. Psychopharmacol. Neurosci."},{"issue":"9","key":"10.1016\/j.biopha.2020.110912_bib0165","doi-asserted-by":"crossref","first-page":"3232","DOI":"10.2337\/db13-0430","article-title":"Antipsychotic-induced insulin resistance and postprandial hormonal dysregulation independent of weight gain or psychiatric disease","volume":"62","author":"Teff","year":"2013","journal-title":"Diabetes"},{"issue":"1-3","key":"10.1016\/j.biopha.2020.110912_bib0170","doi-asserted-by":"crossref","first-page":"90","DOI":"10.1016\/j.schres.2011.06.004","article-title":"Atypical antipsychotics and effects of muscarinic, serotonergic, dopaminergic and histaminergic receptor binding on insulin secretion in vivo: an animal model","volume":"131","author":"Hahn","year":"2011","journal-title":"Schizophr. Res."},{"issue":"1-2","key":"10.1016\/j.biopha.2020.110912_bib0175","doi-asserted-by":"crossref","first-page":"250","DOI":"10.1016\/j.psychres.2008.01.011","article-title":"Metformin plus sibutramine for olanzapine-associated weight gain and metabolic dysfunction in schizophrenia: a 12-week double-blind, placebo-controlled pilot study","volume":"159","author":"Baptista","year":"2008","journal-title":"Psychiatry Res."},{"issue":"3","key":"10.1016\/j.biopha.2020.110912_bib0180","doi-asserted-by":"crossref","first-page":"192","DOI":"10.1177\/070674370605100310","article-title":"Metformin for prevention of weight gain and insulin resistance with olanzapine: a double-blind placebo-controlled trial","volume":"51","author":"Baptista","year":"2006","journal-title":"Can. J. Psychiatry"},{"key":"10.1016\/j.biopha.2020.110912_bib0185","doi-asserted-by":"crossref","first-page":"18","DOI":"10.1016\/j.cellimm.2017.03.001","article-title":"Role of immune cells in obesity induced low grade inflammation and insulin resistance","volume":"315","author":"Asghar","year":"2017","journal-title":"Cell. Immunol."},{"issue":"1","key":"10.1016\/j.biopha.2020.110912_bib0190","doi-asserted-by":"crossref","first-page":"105","DOI":"10.1002\/jcb.26174","article-title":"Tumor necrosis factor-alpha: role in development of insulin resistance and pathogenesis of type 2 diabetes mellitus","volume":"119","author":"Akash","year":"2018","journal-title":"J. Cell. Biochem."},{"issue":"3","key":"10.1016\/j.biopha.2020.110912_bib0195","doi-asserted-by":"crossref","first-page":"229","DOI":"10.1615\/CritRevEukaryotGeneExpr.2017019712","article-title":"Role of Interleukin-6 in development of insulin resistance and type 2 diabetes mellitus","volume":"27","author":"Rehman","year":"2017","journal-title":"Crit. Rev. Eukaryot. Gene Expr."},{"issue":"1","key":"10.1016\/j.biopha.2020.110912_bib0200","doi-asserted-by":"crossref","first-page":"1582","DOI":"10.1038\/s41598-018-36930-y","article-title":"Chronic olanzapine administration causes metabolic syndrome through inflammatory cytokines in rodent models of insulin resistance","volume":"9","author":"Li","year":"2019","journal-title":"Sci. Rep."},{"issue":"3","key":"10.1016\/j.biopha.2020.110912_bib0205","doi-asserted-by":"crossref","first-page":"797","DOI":"10.2337\/db10-0705","article-title":"Differential lipid partitioning between adipocytes and tissue macrophages modulates macrophage lipotoxicity and M2\/M1 polarization in obese mice","volume":"60","author":"Prieur","year":"2011","journal-title":"Diabetes"},{"issue":"6","key":"10.1016\/j.biopha.2020.110912_bib0210","doi-asserted-by":"crossref","first-page":"1907","DOI":"10.2337\/db15-0090","article-title":"Pleiotropic benefits of metformin: macrophage targeting its anti-inflammatory mechanisms","volume":"64","author":"Hattori","year":"2015","journal-title":"Diabetes"},{"issue":"10","key":"10.1016\/j.biopha.2020.110912_bib0215","doi-asserted-by":"crossref","first-page":"2659","DOI":"10.2337\/db16-1446","article-title":"Myeloid sirtuin 6 deficiency causes insulin resistance in high-fat diet-fed mice by eliciting macrophage polarization toward an M1 phenotype","volume":"66","author":"Lee","year":"2017","journal-title":"Diabetes"},{"issue":"2","key":"10.1016\/j.biopha.2020.110912_bib0220","doi-asserted-by":"crossref","first-page":"191","DOI":"10.1038\/nm1185","article-title":"IKK-beta links inflammation to obesity-induced insulin resistance","volume":"11","author":"Arkan","year":"2005","journal-title":"Nat. Med."},{"key":"10.1016\/j.biopha.2020.110912_bib0225","doi-asserted-by":"crossref","DOI":"10.1016\/j.lfs.2020.117442","article-title":"Berberine attenuated olanzapine-induced metabolic alterations in mice: targeting transient receptor potential vanilloid type 1 and 3 channels","volume":"247","author":"Singh","year":"2020","journal-title":"Life Sci."},{"issue":"5","key":"10.1016\/j.biopha.2020.110912_bib0230","doi-asserted-by":"crossref","first-page":"413","DOI":"10.1111\/1440-1681.13073","article-title":"NF-\u03baB as the mediator of metformin\u2019s effect on ageing and ageing-related diseases","volume":"46","author":"Kanigur Sultuybek","year":"2019","journal-title":"Clin. Exp. Pharmacol. Physiol."},{"issue":"9","key":"10.1016\/j.biopha.2020.110912_bib0235","doi-asserted-by":"crossref","first-page":"363","DOI":"10.1089\/jir.2018.0061","article-title":"Metformin inhibits chemokine expression through the AMPK\/NF-\u03baB signaling pathway","volume":"38","author":"Ye","year":"2018","journal-title":"J. Interferon Cytokine Res."}],"container-title":["Biomedicine &amp; Pharmacotherapy"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0753332220311045?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0753332220311045?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,10,23]],"date-time":"2026-10-23T01:51:42Z","timestamp":1792720302000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0753332220311045"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,1]]},"references-count":47,"alternative-id":["S0753332220311045"],"URL":"https:\/\/doi.org\/10.1016\/j.biopha.2020.110912","relation":{},"ISSN":["0753-3322"],"issn-type":[{"value":"0753-3322","type":"print"}],"subject":[],"published":{"date-parts":[[2021,1]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Metformin ameliorates olanzapine-induced insulin resistance via suppressing macrophage infiltration and inflammatory responses in rats","name":"articletitle","label":"Article Title"},{"value":"Biomedicine & Pharmacotherapy","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.biopha.2020.110912","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2020 The Authors. Published by Elsevier Masson SAS.","name":"copyright","label":"Copyright"}],"article-number":"110912"}}